Marcos MA - Search Results

1

Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients.

Liapikou A, Polverino E, Ewig S, Cillóniz C, Marcos MA, Mensa J, Bello S, Martin-Loeches I, Menéndez R, Torres A. Liapikou A, et al. Among authors: marcos ma. Eur Respir J. 2012 Apr;39(4):855-61. doi: 10.1183/09031936.00067111. Epub 2011 Sep 15. Eur Respir J. 2012. PMID: 21920895 Free article.

2

C-reactive protein levels in community-acquired pneumonia.

García Vázquez E, Martínez JA, Mensa J, Sánchez F, Marcos MA, de Roux A, Torres A. García Vázquez E, et al. Among authors: marcos ma. Eur Respir J. 2003 Apr;21(4):702-5. doi: 10.1183/09031936.03.00080203. Eur Respir J. 2003. PMID: 12762360 Free article.

3

Mixed community-acquired pneumonia in hospitalised patients.

de Roux A, Ewig S, García E, Marcos MA, Mensa J, Lode H, Torres A. de Roux A, et al. Among authors: marcos ma. Eur Respir J. 2006 Apr;27(4):795-800. doi: 10.1183/09031936.06.00058605. Eur Respir J. 2006. PMID: 16585087 Free article.

4

Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome.

Dambrava PG, Torres A, Vallès X, Mensa J, Marcos MA, Peñarroja G, Camps M, Estruch R, Sánchez M, Menéndez R, Niederman MS. Dambrava PG, et al. Among authors: marcos ma. Eur Respir J. 2008 Oct;32(4):892-901. doi: 10.1183/09031936.00163407. Epub 2008 Jun 11. Eur Respir J. 2008. PMID: 18550608 Free article.

5

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, Torres A. Ruiz M, et al. Among authors: marcos ma. Am J Respir Crit Care Med. 1999 Aug;160(2):397-405. doi: 10.1164/ajrccm.160.2.9808045. Am J Respir Crit Care Med. 1999. PMID: 10430704

6

Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications.

Arancibia F, Ewig S, Martinez JA, Ruiz M, Bauer T, Marcos MA, Mensa J, Torres A. Arancibia F, et al. Among authors: marcos ma. Am J Respir Crit Care Med. 2000 Jul;162(1):154-60. doi: 10.1164/ajrccm.162.1.9907023. Am J Respir Crit Care Med. 2000. PMID: 10903235

7

Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance?

Bauer T, Ewig S, Marcos MA, Schultze-Werninghaus G, Torres A. Bauer T, et al. Among authors: marcos ma. Med Clin North Am. 2001 Nov;85(6):1367-79. doi: 10.1016/s0025-7125(05)70385-0. Med Clin North Am. 2001. PMID: 11680107 Review.

8

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults.

Marcos MA, Jiménez de Anta MT, de la Bellacasa JP, González J, Martínez E, García E, Mensa J, de Roux A, Torres A. Marcos MA, et al. Eur Respir J. 2003 Feb;21(2):209-14. doi: 10.1183/09031936.03.00058802. Eur Respir J. 2003. PMID: 12608431 Free article.

9

Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?

Sánchez F, Mensa J, Martínez JA, García E, Marco F, González J, Marcos MA, Soriano A, Torres A. Sánchez F, et al. Among authors: marcos ma. Clin Infect Dis. 2003 May 15;36(10):1239-45. doi: 10.1086/374846. Epub 2003 May 6. Clin Infect Dis. 2003. PMID: 12746768 Clinical Trial.

10

Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.

García Vázquez E, Mensa J, Martínez JA, Marcos MA, Puig J, Ortega M, Torres A. García Vázquez E, et al. Among authors: marcos ma. Eur J Clin Microbiol Infect Dis. 2005 Mar;24(3):190-5. doi: 10.1007/s10096-005-1295-9. Eur J Clin Microbiol Infect Dis. 2005. PMID: 15782278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page